Tower Research Capital (TRC)’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87.5K Buy
9,937
+8,552
+617% +$75.3K ﹤0.01% 2487
2025
Q1
$10.4K Sell
1,385
-232
-14% -$1.74K ﹤0.01% 3643
2024
Q4
$13.5K Sell
1,617
-5,618
-78% -$46.9K ﹤0.01% 3524
2024
Q3
$50.2K Sell
7,235
-1,621
-18% -$11.3K ﹤0.01% 2720
2024
Q2
$43.4K Buy
8,856
+8,585
+3,168% +$42.1K ﹤0.01% 3210
2024
Q1
$1.57K Sell
271
-9,402
-97% -$54.5K ﹤0.01% 5242
2023
Q4
$63.4K Buy
9,673
+5,545
+134% +$36.3K ﹤0.01% 2974
2023
Q3
$19.9K Buy
4,128
+1,669
+68% +$8.05K ﹤0.01% 3378
2023
Q2
$12.5K Buy
+2,459
New +$12.5K ﹤0.01% 3835
2023
Q1
Sell
-16,026
Closed -$74K 6350
2022
Q4
$74K Buy
16,026
+9,985
+165% +$46.1K ﹤0.01% 2066
2022
Q3
$38K Sell
6,041
-233
-4% -$1.47K ﹤0.01% 3408
2022
Q2
$28K Sell
6,274
-21,969
-78% -$98K ﹤0.01% 3459
2022
Q1
$142K Buy
28,243
+10,896
+63% +$54.8K ﹤0.01% 1976
2021
Q4
$151K Buy
17,347
+15,146
+688% +$132K ﹤0.01% 1972
2021
Q3
$21K Buy
2,201
+295
+15% +$2.82K ﹤0.01% 3682
2021
Q2
$24K Sell
1,906
-63,079
-97% -$794K ﹤0.01% 3740
2021
Q1
$597K Buy
+64,985
New +$597K 0.01% 1089
2019
Q1
Sell
-332
Closed -$9K 4349
2018
Q4
$9K Buy
332
+126
+61% +$3.42K ﹤0.01% 2580
2018
Q3
$16K Sell
206
-203
-50% -$15.8K ﹤0.01% 2494
2018
Q2
$43K Buy
409
+404
+8,080% +$42.5K ﹤0.01% 1931
2018
Q1
$1K Buy
+5
New +$1K ﹤0.01% 3114
2017
Q4
Sell
-153
Closed -$9K 4180
2017
Q3
$9K Sell
153
-28
-15% -$1.65K ﹤0.01% 3123
2017
Q2
$12K Buy
181
+165
+1,031% +$10.9K ﹤0.01% 1528
2017
Q1
$1K Sell
16
-40
-71% -$2.5K ﹤0.01% 2868
2016
Q4
$3K Sell
56
-154
-73% -$8.25K ﹤0.01% 3300
2016
Q3
$15K Buy
+210
New +$15K ﹤0.01% 1805
2016
Q2
Sell
-43
Closed -$10K 5068
2016
Q1
$10K Buy
43
+38
+760% +$8.84K ﹤0.01% 1990
2015
Q4
$2K Sell
5
-1
-17% -$400 ﹤0.01% 3833
2015
Q3
$2K Buy
+6
New +$2K ﹤0.01% 3418